直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

We share our Insights on a regular basis.

Media Contacts
Terra Liddell
Chief Marketing Officer
Washington, DC
Email
Angela Robinson
Director of Branding and Communications
Washington, DC
Email

IP Updates

Unified Patent Court (UPC) Hub

2026

Articles

When the Classroom Goes Dark: Lessons from the Canvas Breach for Corporate Cyber Preparedness

July 8, 2026

Articles

Enforcing Your Patent Rights at Sea: A UK Perspective

June 18, 2026

Articles

EPR Academy, Part 4 of 6: Choosing Between EPR, IPR, PGR, and Reissue

July 1, 2026

Articles

Highlights and Implications of the UK Corporate Plan for the UKIPO

July 17, 2026

Webinar

Successful Strategies to Win Alice Motions and Fee Awards in Patent Cases Against Non-Practicing Entities

July 22, 2026

IP Updates

Too Concrete to Fail: Ceiva’s Guidance on the Use of Sufficiently Concrete Structures to Overcome Section 101 Rejections

July 28, 2026

At the PTAB Blog

Deadline Evolution: Director Extends Deadline for Requesting Director Review of Institution Grants to 30 Days

June 30, 2026

Federal Circuit IP Blog

“2” Does Not Provide Written Description Support for “1”: Federal Circuit Affirms District Court’s Invalidation of Patent

July 8, 2026

Articles

California Reaches Record $12.75 Million CCPA Settlement with General Motors Over Driver Data

June 4, 2026

Never miss an Insight.

Sign up

Recent Insights

to

Workshop

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Protecting Innovation in the Life Sciences: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 7, 2026

Cambridge

European IP Blog

T 0137/24 and Securing Effective Protection for Biologics T 0137/24 and Securing Effective Protection for Biologics

1 May 2026

European IP Blog

Precision Breeding in England: Navigating the New Regulatory Framework Precision Breeding in England: Navigating the New Regulatory Framework

9 December 2025

Articles

EPO Referral May Shift Patent Description Amendment Rules

EPO Referral May Shift Patent Description Amendment Rules EPO Referral May Shift Patent Description Amendment Rules

November 4, 2025

Law360

European IP Blog

Colour Drawings at the EPO: What You Need to Know Colour Drawings at the EPO: What You Need to Know

1 October 2025

European IP Blog

Description Amendments in the Spotlight – A Referral to the Enlarged Board in G 1/25 Description Amendments in the Spotlight – A Referral to the Enlarged Board in G 1/25

7 August 2025

Seminar

Basel: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets

Basel: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets Basel: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets

May 16, 2024

Basel

Seminar

Copenhagen: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets

Copenhagen: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets Copenhagen: Life Sciences IP Seminar: Multijurisdictional Considerations for Protecting Your Most Valuable Assets

May 14, 2024

Copenhagen

Workshop

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law

May 2, 2024

Cambridge

Webinar

Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed

Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed Navigating Your Life Sciences Opposition: Tips for Best Practice When You Are Opposing or Opposed

December 12, 2023

Webinar

European IP Blog

The EPO’s “10 Day Notification Period” Comes to an End The EPO’s “10 Day Notification Period” Comes to an End

11 October 2023

European IP Blog

The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO The Implausibility of “Plausibility” as an Evidentiary Standard at the EPO

March 24, 2023

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP